ORTEXORTEX News
Tracking LYV? Get live short interest, options flow, and signals on ORTEX.Sign up free →
LY
Earnings PreviewLYV

Live Nation Short Interest Climbs as Analysts Split on Valuation Ceiling

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 2 Nov 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Live Nation Entertainment enters its November 5 results with short sellers more active than at any point in recent months, even as a majority of analysts maintain targets well above the current price.

Short interest has climbed to 10.7% of the free float, up roughly 4.7% over the past week and 3.2% over the past month, placing LYV among the more heavily shorted names in the entertainment sector. Close peer LLYV tracks LYV with a 91% correlation and rose 4.3% on the week, roughly in line with LYV's 2.6% gain. DIS diverged, falling 1.4% over the same period. The borrow market remains accessible despite the elevated short interest: availability is running at 319%, meaning there are more than three times as many shares available to lend as are currently borrowed, and the cost to borrow is just 0.45%. Nothing in the lending market suggests a squeeze is building. Options positioning has eased slightly, with the put/call ratio at 1.23, modestly below its 20-day average of 1.34, a small signal that near-term hedging demand has softened rather than intensified ahead of the print.

The analyst community is broadly constructive but divided on how much further the stock can run. Morgan Stanley lifted its target to $215 last month while keeping its Overweight rating, and most of the Street clusters in the $210 to $218 range. That implies meaningful upside from the current $177.89. The dissent comes from Susquehanna, which trimmed its target to $183 while holding at Neutral, a reflection of the bear case that valuation already prices in strong FY2027 and FY2028 EBITDA without much room for error. The bull argument rests on the company's structural position: $6.6 billion in event-related deferred revenue, approximately 107 million tickets sold for 2026 (up 11% year-over-year), and over 85% of large venue shows already booked. The PE multiple of 117x and price-to-book of 44x are cited on the other side as evidence that the stock's story needs to keep delivering.

The ownership backdrop adds another layer. Liberty Media, filing under Schedule 13D, controls roughly 29.7% of shares through Liberty Live Holdings. That is an activist-classified position on the ORTEX register, though Liberty's role here is that of a committed strategic holder rather than a traditional agitator. Shares are "as last disclosed" around filing thresholds and stakes can fall below 5% without a further filing. FMR added around 2.8 million shares in the period ending August 31, the largest recent institutional move in the data, while CEO Michael Rapino holds close to 1.8% of shares outstanding. The only open-market insider sale in the last 90 days was a modest $534,000 disposal by the Chief Accounting Officer in August, with all other recent filings related to tax withholding on compensation.

The ORTEX short score has drifted higher through October, reaching 71.9, its firmest reading in recent weeks. The November 5 print will test whether the gap between deferred revenue momentum and the sceptics' concern about consumer discretionary softness reflects a genuine fundamental divergence or simply the cost of owning the world's largest live-events platform at a premium multiple.

Stocks in this article

See the live data behind this article on ORTEX.

Open LYV on ORTEX →

How this article was generated

Generated
2 Nov 2026, 04:17
Data as of
2 Nov 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.